Cargando…
In silico analysis of alternative splicing on drug-target gene interactions
Identifying and evaluating the right target are the most important factors in early drug discovery phase. Most studies focus on one protein ignoring the multiple splice-variant or protein-isoforms, which might contribute to unexpected therapeutic activity or adverse side effects. Here, we present co...
Autores principales: | Ji, Yanrong, Mishra, Rama K., Davuluri, Ramana V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954184/ https://www.ncbi.nlm.nih.gov/pubmed/31924844 http://dx.doi.org/10.1038/s41598-019-56894-x |
Ejemplares similares
-
Deep multi-omics integration by learning correlation-maximizing representation identifies prognostically stratified cancer subtypes
por: Ji, Yanrong, et al.
Publicado: (2023) -
Genomic structure and alternative splicing of murine R2B receptor protein tyrosine phosphatases (PTPκ, μ, ρ and PCP-2)
por: Besco, Julie, et al.
Publicado: (2004) -
Genome-wide analysis of alternative promoters of human genes using a custom promoter tiling array
por: Singer, Gregory AC, et al.
Publicado: (2008) -
Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
por: Shilpi, Arunima, et al.
Publicado: (2019) -
NPEBseq: nonparametric empirical bayesian-based procedure for differential expression analysis of RNA-seq data
por: Bi, Yingtao, et al.
Publicado: (2013)